Mary Beth Harler, Chief Executive Officer at IGM Biosciences, Inc. (IGMS), sold 7,329 shares at $1.23 ($9K) on 2025-03-14, disclosed to the SEC on 2025-03-18.
Open-market sale of $9k IGMS by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IGMS | SELL | 2024-12-18 | $13K | — | Filing → |
| IGMS | SELL | 2024-09-17 | $17K | — | Filing → |
| IGMS | SELL | 2024-06-18 | $12K | — | Filing → |